Darryl Carrington

Darryl Carrington has extensive work experience in the medical and pharmaceutical industry. Darryl currently holds the position of Associate Director, Global Clinical Study Management at BeiGene since January 2023. Prior to that, they served as Senior Global Clinical Study Manager at BeiGene from January 2022 to January 2023.

Before joining BeiGene, Darryl was the Director of Clinical Operations for the Asia Pacific region at Telix Pharmaceuticals Limited from May 2021 to December 2021.

Prior to their role at Telix Pharmaceuticals Limited, Darryl had a long tenure at GSK where they held several positions. From October 2017 to April 2021, they were the Director of Third Party Risk and Oversight Asia Pacific. Darryl also served as an Area Manager for Clinical Operations Asia Pacific from January 2016 to October 2017. Darryl started their career at GSK as a Clinical Research Associate in August 2006 and quickly advanced to roles such as Clinical Research Manager and Senior Clinical Research Scientist.

Darryl also has experience at Prana Biotechnology as a Preclinical and CMC Project Manager from an unknown start date until August 2006. Darryl began their career in the research field as a Research Assistant at the Mental Health Research Institute from 2000 to August 2004, and subsequently at the Murdoch Childrens Research Institute from April 1997 to October 2000.

Darryl Carrington earned a Bachelor's degree in Law from Deakin University, completing their studies from 2019 to 2022. Prior to that, they obtained a Master of Biotechnology and Business from RMIT University from 2003 to 2006. Darryl'sundergraduate education also took place at RMIT University, where they earned a Bachelor of Applied Science (Honours) in Applied Biology/Biotechnology from 1993 to 1996.